OR WAIT null SECS
July 22, 2021
Wesam Badran looks at how the UK NHS can collaborate with pharma and med-tech partners to encourage digital innovation.
July 15, 2021
Grünenthal‘s Florent Edouard talks about AI‘s “key role in the future of marketing.”
July 08, 2021
Closing the gaps in complex therapy data remains a hurdle, but “getting clever” with AI can offer a path forward.
July 06, 2021
With AI/ML and cognitive technologies set to become a key enabler of the pharma commercialization process, Srini Rajamani outlines how pharma companies can leverage tech effectively.
June 29, 2021
Harvard Business School Professor Joseph B. Fuller talks about the future prospects for pharma sales forces as they face more restrictions on accessing their target physicians and looming concerns of automation.
June 21, 2021
How pharma firms assess their readiness for IDMP (Identification of Medicinal Products) is important for meeting compliance requirements and ensuring they are prepared for the digital product information management future, writes Adnan Jamil.
June 16, 2021
Emerging pharmaceutical technologies can aid in rapid drug and vaccine development — but only if pharma companies prioritize digitization initiatives.
June 09, 2021
How the UK is making progress in this hi-tech field.
June 08, 2021
Coordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.
June 04, 2021
Developing a diversity mindset may begin at the top levels of the organization, but building diversity into the entire drug development life cycle ensures that it is an ongoing priority and a natural requirement of engaging with external stakeholders.
